Peter N. van Harten

2.5k total citations
53 papers, 1.6k citations indexed

About

Peter N. van Harten is a scholar working on Psychiatry and Mental health, Neurology and Clinical Psychology. According to data from OpenAlex, Peter N. van Harten has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 22 papers in Neurology and 7 papers in Clinical Psychology. Recurrent topics in Peter N. van Harten's work include Schizophrenia research and treatment (39 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neurological disorders and treatments (12 papers). Peter N. van Harten is often cited by papers focused on Schizophrenia research and treatment (39 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neurological disorders and treatments (12 papers). Peter N. van Harten collaborates with scholars based in Netherlands, United States and Curacao. Peter N. van Harten's co-authors include Jim van Os, Diederik E. Tenback, P. Roberto Bakker, Glenn E. Matroos, Hans W. Hoek, René S. Kahn, C. J. Slooff, Annemieke M. Boot, Jan K. Buitelaar and Sebastian Walther and has published in prestigious journals such as American Journal of Psychiatry, Neuroscience & Biobehavioral Reviews and The British Journal of Psychiatry.

In The Last Decade

Peter N. van Harten

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter N. van Harten Netherlands 26 1.1k 657 210 200 184 53 1.6k
R. Yassa Canada 25 1.0k 1.0× 537 0.8× 191 0.9× 164 0.8× 216 1.2× 68 1.7k
Panagiotis Ferentinos Greece 22 519 0.5× 352 0.5× 114 0.5× 126 0.6× 283 1.5× 116 1.5k
Nancy L. Earl United States 13 1.3k 1.2× 379 0.6× 169 0.8× 149 0.7× 175 1.0× 23 1.8k
Peter N. van Harten Netherlands 17 436 0.4× 232 0.4× 78 0.4× 106 0.5× 173 0.9× 48 858
Christopher O’Brien United States 21 449 0.4× 1.1k 1.6× 346 1.6× 129 0.6× 64 0.3× 45 1.5k
Siow‐Ann Chong Singapore 23 795 0.7× 101 0.2× 101 0.5× 82 0.4× 201 1.1× 43 1.1k
Cynthia A. Bossie United States 32 1.9k 1.8× 223 0.3× 102 0.5× 180 0.9× 541 2.9× 72 2.4k
Shunichiro Shinagawa Japan 24 913 0.9× 261 0.4× 127 0.6× 302 1.5× 189 1.0× 96 1.6k
P.K. Mölsä Finland 15 633 0.6× 286 0.4× 146 0.7× 117 0.6× 68 0.4× 24 1.4k
Helena Chui United States 16 675 0.6× 350 0.5× 125 0.6× 155 0.8× 51 0.3× 20 1.5k

Countries citing papers authored by Peter N. van Harten

Since Specialization
Citations

This map shows the geographic impact of Peter N. van Harten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. van Harten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. van Harten more than expected).

Fields of papers citing papers by Peter N. van Harten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. van Harten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. van Harten. The network helps show where Peter N. van Harten may publish in the future.

Co-authorship network of co-authors of Peter N. van Harten

This figure shows the co-authorship network connecting the top 25 collaborators of Peter N. van Harten. A scholar is included among the top collaborators of Peter N. van Harten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter N. van Harten. Peter N. van Harten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deenik, Jeroen, et al.. (2024). Sleep and physical activity patterns in relation to daily-life symptoms in psychosis: An actigraphy and experience sampling study. Psychiatry Research. 344. 116320–116320. 3 indexed citations
3.
4.
5.
Hoeken, Daphne van, et al.. (2020). Proxy WHO Disability Assessment Schedule 2.0 Is Clinically Useful for Assessing Psychosocial Functioning in Severe Mental Illness. Frontiers in Psychiatry. 11. 303–303. 12 indexed citations
6.
Harten, Peter N. van, Sebastian Walther, Jerillyn S. Kent, Scott R. Sponheim, & Vijay A. Mittal. (2017). The clinical and prognostic value of motor abnormalities in psychosis, and the importance of instrumental assessment. Neuroscience & Biobehavioral Reviews. 80. 476–487. 78 indexed citations
7.
Buitelaar, Jan K., et al.. (2012). Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone. Journal of Child and Adolescent Psychopharmacology. 22(6). 432–439. 36 indexed citations
8.
Tenback, Diederik E., et al.. (2012). Efficacy and Safety of Deep Brain Stimulation in Patients With Medication-Induced Tardive Dyskinesia and/or Dystonia. The Journal of Clinical Psychiatry. 73(11). 1434–1438. 39 indexed citations
9.
Harten, Peter N. van, Jan K. Buitelaar, Diederik E. Tenback, et al.. (2012). Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment. European Journal of Endocrinology. 167(6). 855–863. 25 indexed citations
10.
Koning, Jeroen, Jelle Vehof, Huibert Burger, et al.. (2011). Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients. Psychopharmacology. 219(3). 727–736. 32 indexed citations
11.
Tenback, Diederik E., Peter N. van Harten, & Jim van Os. (2009). Non‐therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: A meta‐analysis. Movement Disorders. 24(16). 2309–2315. 53 indexed citations
12.
Harten, Peter N. van, et al.. (2009). Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects. Journal of Child and Adolescent Psychopharmacology. 19(4). 403–414. 79 indexed citations
13.
Koning, Jeroen, Diederik E. Tenback, Jim van Os, et al.. (2008). Dyskinesia and Parkinsonism in Antipsychotic-Naive Patients With Schizophrenia, First-Degree Relatives and Healthy Controls: A Meta-analysis. Schizophrenia Bulletin. 36(4). 723–731. 95 indexed citations
14.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, & Jim van Os. (2007). Evidence that lithium protects against tardive dyskinesia: The Curaçao Extrapyramidal Syndromes study VI. European Neuropsychopharmacology. 18(2). 152–155. 15 indexed citations
15.
Tenback, Diederik E., Peter N. van Harten, C. J. Slooff, & Jim van Os. (2007). Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study. Comprehensive Psychiatry. 48(5). 436–440. 23 indexed citations
16.
Harten, Peter N. van & A. Hovestadt. (2006). Botulinum toxin as a treatment for tardive dyskinesia. Movement Disorders. 21(8). 1276–1277. 22 indexed citations
17.
Tenback, Diederik E., et al.. (2005). Effects of Antipsychotic Treatment on Tardive Dyskinesia. The Journal of Clinical Psychiatry. 66(9). 1130–1133. 40 indexed citations
18.
Harten, Peter N. van. (2005). Folsäure zur Reduktion der Methotrexat-Toxizität. Zeitschrift für Rheumatologie. 64(5). 353–358. 12 indexed citations
19.
Harten, Peter N. van, et al.. (1999). Tardive Dystonia. Schizophrenia Bulletin. 25(4). 741–748. 40 indexed citations
20.
Harten, Peter N. van, Glenn E. Matroos, Hans W. Hoek, & René S. Kahn. (1996). The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao extrapyramidal syndromes study: I. Schizophrenia Research. 19(2-3). 195–203. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Yassa Breakdown of academic impact, for papers by Panagiotis Ferentinos Breakdown of academic impact, for papers by Nancy L. Earl Breakdown of academic impact, for papers by Peter N. van Harten Breakdown of academic impact, for papers by Christopher O’Brien Breakdown of academic impact, for papers by Siow‐Ann Chong Breakdown of academic impact, for papers by Cynthia A. Bossie Breakdown of academic impact, for papers by Shunichiro Shinagawa Breakdown of academic impact, for papers by P.K. Mölsä Breakdown of academic impact, for papers by Helena Chui
Rankless by CCL
2026